Tvardi Therapeutics, Inc. (TVRD)

NASDAQ

$1.31

$-0.01

(-0.76%)

Pre-Market

Tvardi Therapeutics, Inc. (TVRD) Live Price Chart

Last updated: ⁦2026-09-29 11:51:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Tvardi Therapeutics, Inc. (TVRD) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.31, with a market capitalization of $17.74M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.93 to $43.65. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$17.74M
Open	$1.32
Day's High	$43.65
Day's Low	$0.93
Previous Close	$1.33
Volume	--
Average Volume	2.28M
P/E Ratio	--
52-Week High	$43.65
52-Week Low	$0.93
Dividend Yield	--
Earnings Date	--

Tvardi Therapeutics, Inc. (TVRD) Pre-Market Stock Price

Tvardi Therapeutics, Inc. (TVRD) is trading at $1.31 in pre-market trading as of 2026-09-29 10:44:00, down 1.20% ($0.02) from the previous close of $1.33

Pre-market trading shows how investors are pricing TVRD before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.

Tvardi Therapeutics, Inc. (TVRD) 7-Day Stock Price Change

Over the past seven days, Tvardi Therapeutics, Inc. (TVRD) moved from $1.61 to $1.31, representing a decline of 18.39% ($0.30).

The stock traded between $0.93 and $1.73 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.

The average daily volume was 335.28 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

TVRD 52-Week Price Position

Position in Range: 0.9%

52W Low$0.93

52W High$43.65

TVRD is currently trading at $1.31, placing it 0.9% of the way from its 52-week low of $0.93 to its 52-week high of $43.65. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Tvardi Therapeutics, Inc. (TVRD)?

Tvardi Therapeutics Inca clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting Signal Transducer and Activator of Transcription 3 (STAT3) to treat inflammatory and proliferative diseases with unmet need. Its pipeline includes two oral, small molecule STAT3 inhibitors: TTI-101 and TTI-109. TTI-101 is its first-generation direct STAT3 inhibitor, currently in Phase 1b/2 clinical development in hepatocellular carcinoma (HCC). TTI-109 is a phosphate prodrug of TTI-101 that is mechanistically identical to its parent molecule but is designed to enhance its ability to target STAT3.

Tvardi Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	12
Exchange	NASDAQ
Company Website	https://www.tvarditherapeutics.com

How to Buy Tvardi Therapeutics, Inc. (TVRD) Stock on MEXC

Eligible investors can buy real shares of Tvardi Therapeutics, Inc. (TVRD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for TVRD and Place Your Order

Open the RealStocks trading page and search for TVRD. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Tvardi Therapeutics, Inc. (TVRD) stock price today?

Tvardi Therapeutics, Inc. (TVRD) is currently trading at $ 1.31, down 1.20% ($0.02) from the previous close of $ 1.33. Intraday prices update in real time during regular trading hours.

2.Is TVRD stock going up or down today?

As of 2026-09-29 10:44:00, TVRD is trading at $ 1.31, down 1.20% ($0.02) from its previous close of $ 1.33. The stock has traded between $ 0.93 and $ 43.65 during today’s regular session. Past price movements do not guarantee future results.

3.What is TVRD pre-market price?

As of 2026-09-29 10:44:00, TVRD is trading at $ 1.31 in pre-market trading, down 1.20% ($0.02) from the previous close of $ 1.33. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is TVRD after-hours price?

As of 2026-09-29 10:44:00, TVRD is trading at $ 1.33 in after-hours trading, unchanged from the regular-session close of $ 1.33. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is TVRD stock trading now?

TVRD trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does TVRD sit relative to its 52-week high and low?

Over the past 52 weeks, TVRD has traded between a low of $ 0.93 and a high of $ 43.65. At $ 1.31, the stock is positioned 0.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Tvardi Therapeutics, Inc. in?

Tvardi Therapeutics, Inc. (TVRD) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Tvardi Therapeutics, Inc.'s market capitalization and where is it listed?

Tvardi Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 17.74M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is TVRD valued in terms of P/E ratio and EPS?

TVRD trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.95. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Tvardi Therapeutics, Inc. pay a dividend?

Tvardi Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.